We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+10.88%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.12B
AUM Growth
+$596M
Cap. Flow
+$91.3M
Cap. Flow %
1.28%
Top 10 Hldgs %
11.77%
Holding
645
New
72
Increased
209
Reduced
241
Closed
76

Top Sells

Rank Stock Value
1
REVG
REV Group
REVG
+$46.8M
2
UNH icon
UnitedHealth
UNH
+$43.8M
3
AZEK
The AZEK Co
AZEK
+$23.3M
4
MCK icon
McKesson
MCK
+$21.1M
5
TJX icon
TJX Companies
TJX
+$17.8M

Sector Composition

Rank Sector Weight
1 Technology 20.65%
2 Industrials 18.36%
3 Financials 15.32%
4 Healthcare 12.69%
5 Consumer Discretionary 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MANH icon
176
Manhattan Associates
MANH
$12.1B
$13.9M 0.19%
70,226
+29,696
+73% +$5.39M
TJX icon
177
TJX Companies
TJX
$179B
$13.6M 0.19%
109,877
-140,004
-56% -$17.8M
AZEK
178
DELISTED
The AZEK Co
AZEK
$13.5M 0.19%
249,208
-464,594
-65% -$23.3M
ECG
179
Everus Construction Group
ECG
$5.57B
$13.5M 0.19%
212,798
+36,193
+20% +$1.83M
ANGO icon
180
AngioDynamics
ANGO
$605M
$13.5M 0.19%
1,356,692
-27,747
-2% -$272K
TRU icon
181
TransUnion
TRU
$16B
$13.4M 0.19%
+151,948
New +$12.7M
CDNS icon
182
Cadence Design Systems
CDNS
$91.8B
$13.3M 0.19%
43,164
-46,259
-52% -$13.5M
NOVT icon
183
Novanta
NOVT
$4.91B
$13M 0.18%
101,054
+44,149
+78% +$5.37M
GNTX icon
184
Gentex
GNTX
$5.1B
$13M 0.18%
591,391
+98,480
+20% +$2.15M
VCYT icon
185
Veracyte
VCYT
$4.45B
$12.9M 0.18%
476,295
+7,640
+2% +$221K
MORN icon
186
Morningstar
MORN
$7.55B
$12.8M 0.18%
40,792
+2,576
+7% +$763K
ARCB icon
187
ArcBest
ARCB
$3.15B
$12.8M 0.18%
165,592
-3,794
-2% -$247K
GKOS icon
188
Glaukos
GKOS
$9.49B
$12.6M 0.18%
122,396
+20,717
+20% +$1.94M
BRO icon
189
Brown & Brown
BRO
$25.1B
$12.6M 0.18%
113,762
-4,728
-4% -$531K
ORLY icon
190
O'Reilly Automotive
ORLY
$75.1B
$12.5M 0.18%
138,621
-162,804
-54% -$14.8M
CMCO icon
191
Columbus McKinnon
CMCO
$422M
$12.4M 0.17%
814,202
+28,049
+4% +$429K
VLTO icon
192
Veralto
VLTO
$24.3B
$12.4M 0.17%
122,893
-2,994
-2% -$289K
RSG icon
193
Republic Services
RSG
$67.4B
$12.4M 0.17%
50,134
-41,627
-45% -$10.3M
TSM icon
194
TSMC
TSM
$1.94T
$12.2M 0.17%
53,881
-16,246
-23% -$3.01M
MDYG icon
195
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.76B
$12.2M 0.17%
140,262
-2,573
-2% -$210K
EME icon
196
Emcor
EME
$29.9B
$12.1M 0.17%
22,589
-6,669
-23% -$2.94M
KNF icon
197
Knife River
KNF
$4.33B
$12.1M 0.17%
147,721
+25,371
+21% +$2.31M
IBP icon
198
Installed Building Products
IBP
$6.21B
$12M 0.17%
66,538
+11,239
+20% +$1.87M
INSM icon
199
Insmed
INSM
$22.4B
$12M 0.17%
119,136
-51,723
-30% -$3.95M
SITE icon
200
SiteOne Landscape Supply
SITE
$4.16B
$11.9M 0.17%
98,737
+16,673
+20% +$1.97M

Similar funds

Segall Bryant & Hamill's Q2 2025 Portfolio in Review

As of Q2 2025, Segall Bryant & Hamill held 645 positions worth $7.12B, up 9.1% from $6.53B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill's Q2 2025 filing shows 72 new, 209 increased, 241 reduced and 76 closed positions. Its largest new stake was Flowserve: 345,600 shares worth $18.1M. The largest sale was REV Group, an estimated $46.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q2 2025 buy was Flowserve: 345,600 shares worth $18.1M.
  • Segall Bryant & Hamill added most to Meta Platforms (Facebook) in Q2 2025, an estimated $28.6M increase.
  • Segall Bryant & Hamill's biggest Q2 2025 reduction was REV Group, cutting an estimated $46.8M.
  • Segall Bryant & Hamill fully exited UnitedHealth in Q2 2025, selling an estimated $43.8M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $7.12B portfolio in Q2 2025.
  • Segall Bryant & Hamill opened 72 new positions and closed 76 in Q2 2025.
  • Segall Bryant & Hamill's portfolio value rose 9.1% quarter-over-quarter to $7.12B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2025, filed 12 Aug 2025.